HEALTHSCIENCE DAILY
Millions may be getting the wrong cholesterol test
A new study indicates that the apoB blood test, which measures harmful cholesterol particles, is more effective than standard LDL cholesterol testing for determining who needs intensive treatment. The test could prevent more heart attacks and strokes while being cost-effective for the U.S. healthcare system.
Mentioned
Related Signal
Adjacent reporting
- Researchers claim £36 high street cholesterol test is better predictor of heart attack and stroke risk than standard GP tests
- Testing for ‘Bad Cholesterol’ Doesn’t Tell the Whole Story
- New blood test detects 90% of aggressive prostate cancer cases, beating current screenings
- 'Holy Grail' blood test could prevent one in five cancer deaths - saving 30,000 lives, breakthrough trial suggests
- New blood test could identify heart and kidney disease years before people fall ill: Patients could benefit from life-changing early interventions
- One in five people may carry this hidden cholesterol risk without knowing it